Human papillomavirus in genital carcinogenesis

Area of Science:

• Virology
• Oncology
• Epidemiology

Background:

• Human papillomavirus (HPV) infections manifest clinically, subclinically, and latently.
• Clinical HPV infections are linked to intraepithelial neoplasia and invasive squamous cell cancer.
• Genital HPV infections exhibit complex biologic behaviors including regression, persistence, and progression.

Purpose of the Study:

• To investigate the prevalence, incidence, and risk factors of human papillomavirus (HPV) infections.
• To analyze the progression patterns of HPV lesions based on grade and HPV type.
• To compare HPV detection rates and type concordance between sexual partners.

Main Methods:

• Diagnosis of clinical HPV infections utilized colposcopy, cytology, and histopathology.
• Subclinical and latent HPV infections were detected using DNA hybridization and polymerase chain reaction (PCR).
• A prospective follow-up study assessed clinical progression, correlating it with lesion grade and HPV type.

Main Results:

• The prevalence of HPV in Papanicolaou smears among young women is 3%, with an annual incidence of 8%.
• Significant risk factors for clinical HPV infection include multiple sexual partners and current smoking.
• Clinical progression was strongly associated with lesion grade (P < 0.0001) and HPV type, with HPV 16 showing over five times the progression rate of HPV 6 or 11.
• HPV detection rates are lower in men (approx. 30%) with low type concordance (5-10%) in couples.

Conclusions:

• HPV infections are highly prevalent, with significant risk factors identified.
• HPV typing, particularly identifying HPV 16, is crucial for predicting clinical progression.
• Understanding HPV epidemiology in both sexes and couples is essential for infection control strategies.